Tivic Health and Reliefband mutually terminate acquisition agreement citing market conditions

Valion Bio, Inc.

Tivic Health and Reliefband Technologies mutually terminated the Asset Purchase Agreement on December 7, 2022.
The deal was announced October 7, 2022; termination follows a review of financing alternatives amid volatile capital markets.
CEO Jennifer Ernst said proceeding with the acquisition is not in the best interest of stakeholders at this time.
Tivic will focus on accelerating ClearUP sales and expanding its organic product pipeline.
Both parties remain on good terms despite disappointment; Tivic will continue to evaluate M&A and partnership opportunities.

item 1.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Valion Bio, Inc. terminated Asset Purchase Agreement with Reliefband Technologies, LLC (effective 2022-12-07).

Action: termination
Agreement: asset purchase
Counterparty: Reliefband Technologies, LLC
Effective: 2022-12-07

Exact text from the filing

On December 7, 2022, pursuant to Section 7.1(a) of the Purchase Agreement, the Company and Reliefband mutually agreed to terminate the Purchase Agreement immediately and abandon the proposed transaction.

View on SEC.gov

38 material agreements filed in the last 30 days. Browse all material agreements →

Valion Bio, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-22-026261

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.